( March 17, 2026, 1:56 PM EDT) -- ST. LOUIS — States challenging the U.S. Food and Drug Administration’s approval of mifepristone, one of two drugs used to induce early termination of pregnancy, should have extra time to respond to a motion to stay filed by the federal government and motions to dismiss filed by drug manufacturers that were allowed to intervene in the case, the parties say in a joint motion filed in a Missouri federal court on March 16....